openPR Logo
Press release

Uprising European Influenza Vaccine Market- Ken Research

06-15-2017 01:53 PM CET | Health & Medicine

Press release from: Ken Research Pvt Ltd

Europe is at the heart of global vaccine research and production. Influenza is a vaccine preventable disease and influenza vaccine has been available for use in Europe since 1960’s.

Approximately, at US$ 1 billion, Europe influenza market was closed. Nevertheless, the highest influenza market share was held by United Kingdom. West Europe has more than US$ 500 Million. United Kingdom, Germany, France, Italy and Spain hold 80 percent of influenza market share. France holds the second post, as United States holds the first post in children vaccine market. In addition, in adult vaccine market, United States and Germany was almost at a same pace.

Seasonal influenza vaccines need a yearly update because of constant evolution of influenza viruses in Europe and other countries as well. The match between selected vaccine virus and those found circulating determine the effectiveness of seasonal influenza vaccine, which vary from year to year. There is a meeting held each year in February, in order to find best match and increase the vaccine efficiency and effectiveness.

According to the market research report "Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis", the immunity that is extended by influenza vaccines is not as long lived as the immunity following natural influenza infection. This is particularly so for those who belong to the risk group, hence people have to be vaccinated yearly. There are three influenza immunization strategies which is feasible but Europe is the country where it is firstly most important and widely used.

Discreet analysis has been made on the part of competitors. There are three major players which have a major share of the influenza vaccine market in terms of revenue.The key influencers with their products in the influenza vaccine market are Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus, AstraZeneca and Protein Sciences Corporation. There are other emerging players as well as if Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd and VaxInnate are making novel technology based influenza vaccine, which may tend to affect the market share in the future.

In Europe, protecting the vulnerable is one of the main strategies of immunization programs, which is to directly or indirectly protect individuals that are more vulnerable. Direct protection involves immunizing people who are more likely to develop austere disease if they are infected by influenza viruses. There is also an indirect protection strategy of immunizing those with close contact with people in risk groups. The importance of this is growingas that the ordinary influenza vaccines are more effective in healthy adults than older people and those with chronic conditions, including immunodeficiency and this is now accelerated. Moreover, children under six months of age that cannot be vaccinated and it may be protected by the indirect ammunition strategies.

To determine how effective influenza vaccines work each season, influenza vaccine efficaciousness is measured in observational studies. Vaccine productiveness is an estimate of the likelihood that a vaccine prevents influenza infection when used in everyday practice. In Europe influenza, vaccine effectiveness studies have been followed according in a desired manner since in year 2008-09, a network of public health and academic researchers. However, results have been come out by age group and by various influenza vaccine strains. In general, a vaccine effectiveness and cooperative assessment has been estimated for the three different influenza A (H1N1, H3N2) and B strains (Victoria or Yamagata lineages) apart from the last two seasons where only a limited effectiveness was observed against influenza yield by circulating H3N2 viruses due to mismatch.

Topics Covered in The Report

Europe Influenza Vaccine Market Research Report
Europe Influenza Vaccine Market Size
Europe Influenza Vaccine Market
Europe Influenza Vaccine Trade Market
Europe Influenza Vaccine Production Output
Europe Influenza Vaccine Import Volume
Europe Influenza Vaccine Export Volume
Europe Influenza Vaccine Market Future Outlook
Europe Influenza Vaccine Market competition
UK Influenza Vaccine Market Research
Germany Influenza Vaccine Market Research
Spain Influenza Vaccine Market Research
Europe Seasonal Influenza Child Vaccine Market
Netherlands Seasonal Influenza Vaccine Market
Denmark Seasonal Influenza Vaccine Market
Finland Seasonal Influenza Vaccine Market
Ireland Seasonal Influenza Vaccine Market
Italy Seasonal Influenza Vaccine Market
Luxembourg Seasonal Influenza Vaccine Market
Romania Seasonal Influenza Vaccine Market
Germany Influenza Vaccine Market Growth
Germany Influenza Vaccine Market future
Germany Influenza Vaccine Market size
Germany Influenza Vaccine Market share

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/europe-influenza-vaccine-market-forecast/104290-91.html

Related reports:

Global Bone Allograft and Xenograft Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Enteric Empty Capsules Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Contact Us:

Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

www.kenresearch.com

Europe Influenza Vaccine Market was close to US$ 1 Billion. United Kingdom holds the highest seasonal influenza vaccine market share. United Kingdom, Germany, France, Italy & Spain together holds more than 80 percent of influenza vaccine market share

Contact Us:

Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

www.kenresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uprising European Influenza Vaccine Market- Ken Research here

News-ID: 580179 • Views: 287

More Releases from Ken Research Pvt Ltd

US Seed Market Outlook to 2023: Ken Research
The report titled “US Seed Market Outlook to 2023 - By Type of Seed (Corn, Soybean, Cotton, Wheat, Sorghum, and Vegetables) and By Technology (GM/GE/Hybrid and Open Pollinated)” provides a comprehensive analysis of the seeds market in the US. The report covers the overall market size in terms of revenue, segmentations on the basis of crop, type of seed, geographical region, trends and developments, regulations for patents in the US,
Philippines Logistics and Warehousing Market Outlook to 2024: Ken Research
The report titled “Philippines Logistics and Warehousing Market Outlook to 2024 – By Freight Forwarding (Air, Sea, Land), Domestic and International Freight Flow Corridor; By Warehousing (Industrial/Retail Freight, Container Freight, Cold Storage, Agriculture and Others), Express and E-commerce Logistics, Balikbayan Box, Third Party Logistics” provides a comprehensive analysis of the logistics market of Philippines. The report also covers logistics infrastructure in the country, value chain analysis of the market, the
Growing Ultimatum of the Global Temporary Power System Market Outlook: Ken Resea …
The temporary power system majorly empower of standby generators which involve both gas generators and diesel generators along with the other apparatus. Whereas, the temporary power is devoted to be liberated source of electrical energy which has its effectiveness to help the pivotal electrical systems during the harm of normal supply of power during the precise time period. Generally, the temporary power systems used and deployed to safeguard the power
UK Executive MBA Market Outlook to 2023: Ken Research
The report titled “UK Executive MBA Market Outlook to 2023 - By Type of Program (Structured and Customized), By Electives, By Blended Learning (Online & Offline and only Offline), By Program Duration and By Course Type (Part Time only, Full Time only or Either Full or Part Time)” provides a comprehensive analysis on the Executive MBA Industry of UK. The report covers various aspects including introduction on Executive MBA market,

All 5 Releases


More Releases for Vaccine

Tetanus Toxoid Vaccine Market
The report for Global Tetanus Toxoid Vaccine Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. Market Highlights: Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the
Vaccine Market Demand is Increasing
U.S. Vaccine Market: Snapshot The overall vaccine industry has strengthened itself in terms of its growth rate, with a relatively higher growth rate than most other healthcare market segments. Vaccination has been an invaluable addition to better public health, and has helped millions of children, adults and animals from deadly diseases. The CDC stated in a report that diseases such as diphtheria, polio, and smallpox have been fully eliminated, while measles,
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Peanut Allergy Vaccine Market
Allergies are medical conditions caused primarily by hypersensitivity of the immune system to some external stimulus. Allergy may cause anaphylaxis—a medical condition that can cause irritation of the skin, swelling of throat, shortness of breath, and in some cases, death. Allergies are caused by various allergens such as pollen grains, or certain foods such as peanuts. Vaccination is the process of administering antigenic material or a vaccine to stimulate one’s
Shingles Vaccine Market
The shingles vaccine market revenue is expected to grow at a robust rate over the forecast period. Shingles, also known as herpes zoster, is a viral infection that affects the cranial nerves that originate in the brain. It is caused by the varicella zoster virus, the same virus that also cases chicken pox. The virus can stay dormant for many years in the human body. Therefore, anyone who has had